Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

H. Fernandez, Hubert; T. Boyd, James; S.C. Fung, Victor; Lew, Mark; L. Rodriguez, Ramon; T. Slevin, John; G. Standaert, David; Zadikoff, Cindy; Vanagunas, Arvydas; Chatamra, Krai; Eaton, Susan; Facheris, Maurizio; Hall, Coleen; Robieson, Weining; Benesh, Janet; J. Espay, Alberto

doi:10.1002/mds.27338

Public

Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

Published in Movement Disorders • Mar 23, 2018

Authors:

Hubert H. Fernandez

James T. Boyd

Victor S.C. Fung

Abstract

BACKGROUND: Levodopa-carbidopa intestinal gel (designated as carbidopa-levodopa enteral suspension in the United States) provides stable plasma levodopa concentrations and reduces motor fluctuations in advanced Parkinson's disease patients through continuous delivery of levodopa via percutaneous end...

Subject

Carbidopa

Parkinson's disease

Levodopa

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!